Christel Larbouret
Montpellier, 34090, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Addressing multiple facets of ligand-receptor network inference including single-cell proteomics.
Journal: Nucleic acids research
Published: October 06, 2025
Correction: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.
Journal: Oncotarget
Published: October 11, 2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Journal: Clinical and translational medicine
Published: April 08, 2024
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer.
Journal: Frontiers in immunology
Published: February 17, 2023
Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures.
Journal: Cancers
Published: July 08, 2021
Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
Journal: Cancer science
Published: January 24, 2020
Mimicking polyclonal immune response in therapy: from combination of two monoclonal antibodies to oligoclonal antibody-based mixtures
Journal: Medecine sciences : M/S
Published: January 07, 2020
ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Journal: Cell communication and signaling : CCS
Published: May 07, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
Journal: International journal of cancer
Published: December 21, 2018
Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells.
Journal: International journal of radiation oncology, biology, physics
Published: August 25, 2018
Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates.
Journal: Organic & biomolecular chemistry
Published: February 24, 2018
Last Updated: 09/26/2026